Evaluating the impact of new anticoagulants in the hospital setting

The short-comings of current anticoagulants have led to the development of newer, albeit more expensive, oral alternatives. OBJECTIVE: To explore the potential impact the new anticoagulants dabigatran and rivaroxaban in the local hospital setting, in terms of utilisation and subsequent costing. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Braidy, Nady, Bui, Khai, Bajorek, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132966/
https://www.ncbi.nlm.nih.gov/pubmed/25132883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132966/
https://www.ncbi.nlm.nih.gov/pubmed/25132883

Ejemplares similares